AVAiL

Related by string. avail * * DIRECTV Avail TVN . p avail immed . avail immed . Avail immed . Avail TVN . prudently avail . availing IsoRay Inc. . Revenue Per Avail . RIGHT TO AVAIL OF . prkg avail . Avail Media . avail 1May . p avail 1May . Avail Intelligence . % TOTAL AVAIL . avail 1Apr . avail 1Sept . Avail 1May . avail 1Oct . avails itself . avail 1Mar . avail 1Aug . avail 1Nov . Avail 1Sept *

Related by context. Frequent words. (Click for all words.) 61 axitinib 60 pertuzumab 60 Gynecologic Oncology Group 60 Phase Ib clinical 59 randomized Phase III 58 phase IIa 58 abiraterone 57 Taxotere ® 57 ASA# 57 liver transplant recipients 56 placebo controlled clinical 56 registrational trial 56 Phase Ia 56 HER2 positive metastatic breast 56 XELOX 56 SABCS 56 NSABP 56 phase IIb 55 phase 2a 55 EORTC 55 pharmacodynamic effects 55 ocrelizumab 55 Avastin bevacizumab 55 Pirfenidone 55 Phase 1b clinical 55 randomized controlled clinical trials 55 PRECiSE 55 heavily pretreated 54 Chronic Lymphocytic Leukemia 54 Phase III randomized 54 decitabine 54 prospective observational 54 Phase 1b 54 SWOG 54 Amrubicin 54 abiraterone acetate 54 plus prednisone 54 RRMS patients 54 Phase 1b trial 53 metastatic renal cell carcinoma 53 relapsed refractory multiple myeloma 53 Pivotal Phase III 53 malignant pleural mesothelioma 53 placebo controlled clinical trials 53 eribulin 53 randomized trials 53 Pharmacokinetic 53 Irinotecan 53 multicenter randomized double 53 double blinded placebo 52 Pivotal Phase 52 placebo controlled randomized 52 plus dexamethasone 52 RTOG 52 Torisel 52 dose escalation trial 52 Phenoptin 52 Pivotal Trial 52 refractory multiple myeloma 52 Phase 2b trial 52 substudy 52 Multicenter 52 multicenter clinical 52 temsirolimus 52 sunitinib 52 Tyverb 52 multicenter randomized 52 multicenter 52 Phase IIa trial 51 ATTRACT 51 multicenter study 51 multicentre 51 ZD# [001] 51 nab paclitaxel 51 ataluren 51 Cooperative Oncology 51 hepatocellular carcinoma HCC 51 randomized clinical 51 TRITON TIMI 51 sorafenib 51 Phase 2a trial 51 talabostat 50 BAY #-# 50 placebo controlled 50 chemoradiotherapy 50 Liver Cancer 50 RIBBON 50 National Surgical Adjuvant 50 myelodysplastic syndromes MDS 50 neoadjuvant 50 Cloretazine R VNP#M 50 TASQ 50 adecatumumab 50 tocilizumab 50 romidepsin 50 active comparator 50 RG# [001] 50 Lenalidomide 50 castration resistant prostate cancer 50 vinorelbine 50 Bapineuzumab

Back to home page